| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.33▼ | 5.30▼ | 5.31▼ | 5.35▼ | 5.78▼ |
| MA10 | 5.31▼ | 5.31▼ | 5.27▲ | 5.53▼ | 6.40▼ |
| MA20 | 5.34▼ | 5.25▲ | 5.20▲ | 5.79▼ | 6.82▼ |
| MA50 | 5.24▲ | 5.27▲ | 5.45▼ | 6.54▼ | 8.25▼ |
| MA100 | 5.23▲ | 5.49▼ | 5.62▼ | 7.00▼ | 11.89▼ |
| MA200 | 5.43▼ | 5.73▼ | 5.99▼ | 8.32▼ | 18.02▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | 0.017▲ | 0.033▲ | -0.017▼ | -0.096▼ |
| RSI | 50.614▲ | 52.982▲ | 49.529▼ | 39.046▼ | 36.646▼ |
| STOCH | 61.263 | 32.524 | 47.408 | 30.930 | 10.448▼ |
| WILL %R | -64.000 | -57.143 | -50.000 | -80.405▼ | -92.677▼ |
| CCI | -6.013 | 35.941 | 58.721 | -68.971 | -125.290▼ |
|
Thursday, May 28, 2026 09:01 AM
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
|
|
Wednesday, April 29, 2026 05:00 PM
SOUTH SAN FRANCISCO, Calif., April 30, 2026 (GLOBE NEWSWIRE)-- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through ...
|
|
Thursday, April 23, 2026 05:00 PM
SOUTH SAN FRANCISCO, Calif., April 24, 2026 (GLOBE NEWSWIRE)-- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/06/26 | 5.31 | 5.50 | 5.255 | 5.30 | 164,540 |
| 03/06/26 | 5.22 | 5.33 | 5.06 | 5.14 | 50,173 |
| 02/06/26 | 5.345 | 5.55 | 5.01 | 5.25 | 172,480 |
| 01/06/26 | 5.70 | 5.8522 | 5.295 | 5.35 | 167,039 |
| 29/05/26 | 5.94 | 5.94 | 5.505 | 5.70 | 105,413 |
| 28/05/26 | 5.75 | 5.94 | 5.48 | 5.79 | 195,296 |
| 27/05/26 | 5.74 | 5.75 | 5.455 | 5.60 | 92,829 |
| 26/05/26 | 5.84 | 5.90 | 5.62 | 5.74 | 78,578 |
| 22/05/26 | 5.80 | 6.10 | 5.7101 | 5.76 | 136,141 |
| 21/05/26 | 5.59 | 5.83 | 5.52 | 5.71 | 84,820 |
|
|
||||
|
|
||||
|
|